Yi‐Hung Carol Tan

CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases

Yi‐Hung Carol Tan, Soundararajan Krishnaswamy, Suvobroto Nandi et al. · PLoS ONE · 2010 · 105 citations · Full text

Medicine, Genetics, Oncology +15

A pan-cancer organoid platform for precision medicine

Brian M. Larsen, Madhavi Kannan, Lee Langer et al. · Cell Reports · 2021 · 98 citations · Full text

Medicine, Cancer Biology, Oncology +16

Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

Corey C. Foster, Marcus Couey, Sara Kochanny et al. · Cancer · 2021 · 81 citations · Full text

Medicine, Immunology, Oncology +17

Wild-Type p53 Overexpression and Its Correlation With MDM2 and p14ARF Alterations: An Alternative Pathway to Non–Small-Cell Lung Cancer

Yu-Chien Wang, Ruo-Kai Lin, Yi‐Hung Carol Tan et al. · Journal of Clinical Oncology · 2004 · 78 citations · Full text

Medicine, Molecular Biology, Oncology +15

The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target

Benjamin D. Ferguson, Ren Liu, Cleo E. Rolle et al. · PLoS ONE · 2013 · 74 citations · Full text

Medicine, Molecular Biology, Oncology +17